Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
54.80
+0.90 (1.67%)
Apr 29, 2026, 1:30 PM CST
-20.92%
Market Cap 2.45B
Revenue (ttm) 569.77M
Net Income (ttm) 53.51M
Shares Out 45.38M
EPS (ttm) 1.19
PE Ratio 45.45
Forward PE n/a
Dividend 1.05 (1.95%)
Ex-Dividend Date Jun 26, 2025
Volume 52,243
Average Volume 43,858
Open 53.70
Previous Close 53.90
Day's Range 52.50 - 54.80
52-Week Range 50.60 - 80.40
Beta -0.07
RSI 53.85
Earnings Date May 14, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is... [Read more]

Sector Healthcare
Founded 1959
Employees 172
Stock Exchange Taipei Exchange
Ticker Symbol 4747
Full Company Profile

Financial Performance

In 2025, TPEX:4747's revenue was 569.77 million, a decrease of -6.81% compared to the previous year's 611.42 million. Earnings were 53.51 million, a decrease of -36.40%.

Financial Statements

News

There is no news available yet.